Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
The novel σ receptor ligands; BD 1047 and BD 1063 appear to act as antagonists at σ sites and may represent promising new tools for probing other functional effects associated with σ binding sites. Neurotransmitter antagonists.
您的位置：
